These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22458883)

  • 1. Hepatosplenic candidiasis in the era of new antifungal drugs: a study in Paris 2000-2007.
    De Castro N; Mazoyer E; Porcher R; Raffoux E; Suarez F; Ribaud P; Lortholary O; Molina JM
    Clin Microbiol Infect; 2012 Jun; 18(6):E185-7. PubMed ID: 22458883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia.
    Walsh TJ; Whitcomb PO; Revankar SG; Pizzo PA
    Cancer; 1995 Dec; 76(11):2357-62. PubMed ID: 8635043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatosplenic candidiasis in paediatric haematology-oncology patients].
    Hernández Marqués C; Lassaletta-Atienza A; González-Vicent M; Sevilla J; Molina B; Andión M; Cormenzana M; Pérez Martínez A; Díaz MA; Madero L
    An Pediatr (Barc); 2011 Jul; 75(1):26-32. PubMed ID: 21419736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection.
    Sipsas NV; Lewis RE; Tarrand J; Hachem R; Rolston KV; Raad II; Kontoyiannis DP
    Cancer; 2009 Oct; 115(20):4745-52. PubMed ID: 19634156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
    Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
    Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidemia in patients with hematologic malignancies: analysis of 7 years' experience in a single center.
    Vigouroux S; Morin O; Moreau P; Harousseau JL; Milpied N
    Haematologica; 2006 May; 91(5):717-8. PubMed ID: 16670081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis.
    Rammaert B; Desjardins A; Lortholary O
    Mycoses; 2012 May; 55(3):e74-84. PubMed ID: 22360318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics of hepatosplenic fungal infection in pediatric patients.
    Yen TY; Huang LM; Lee PI; Lu CY; Shao PL; Chang LY
    J Microbiol Immunol Infect; 2011 Aug; 44(4):296-302. PubMed ID: 21524963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications.
    Anttila VJ; Elonen E; Nordling S; Sivonen A; Ruutu T; Ruutu P
    Clin Infect Dis; 1997 Mar; 24(3):375-80. PubMed ID: 9114188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Candida tropicalis fungemia in patients with cancer.
    Kontoyiannis DP; Vaziri I; Hanna HA; Boktour M; Thornby J; Hachem R; Bodey GP; Raad II
    Clin Infect Dis; 2001 Nov; 33(10):1676-81. PubMed ID: 11568858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R; Hanna H; Kontoyiannis D; Jiang Y; Raad I
    Cancer; 2008 Jun; 112(11):2493-9. PubMed ID: 18412153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of breakthrough fungemia caused by azole-resistant Candida tropicalis in patients with hematologic malignancies.
    Myoken Y; Kyo T; Fujihara M; Sugata T; Mikami Y
    Haematologica; 2004 Mar; 89(3):378-80. PubMed ID: 15020289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies.
    Madney Y; Shalaby L; Elanany M; Adel N; Nasr E; Alsheshtawi K; Younes A; Hafez H
    Mycoses; 2020 Jan; 63(1):30-37. PubMed ID: 31514231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High ferritin levels are associated with hepatosplenic candidiasis in hematopoietic stem cell transplant candidates.
    Tunçcan OG; Yegin ZA; Ozkurt ZN; Erbaş G; Akı SZ; Senol E; Yağcı M; Sucak G
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e104-7. PubMed ID: 20307998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009.
    Campo M; Lewis RE; Kontoyiannis DP
    J Infect; 2010 May; 60(5):331-7. PubMed ID: 20138081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of intravenous 5-fluorocytosine during continuous venovenous haemodiafiltration in a patient with hepatosplenic candidiasis.
    Roberts JA; Udy AA; O'Donoghue S; Briscoe S; Paterson DL; Lipman J
    Int J Antimicrob Agents; 2009 Oct; 34(4):383-4. PubMed ID: 19540094
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatosplenic fungal infection in patients with acute leukemia in Taiwan: incidence, treatment, and prognosis.
    Chen CY; Chen YC; Tang JL; Yao M; Huang SY; Tsai W; Chen YC; Shen MC; Wang CH; Tien HF
    Ann Hematol; 2003 Feb; 82(2):93-97. PubMed ID: 12601487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liposomal amphotericin B twice weekly as antifungal prophylaxis in paediatric haematological malignancy patients.
    Bochennek K; Tramsen L; Schedler N; Becker M; Klingebiel T; Groll AH; Lehrnbecher T
    Clin Microbiol Infect; 2011 Dec; 17(12):1868-74. PubMed ID: 21895857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.